SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001753926-24-000584
Filing Date
2024-03-21
Accepted
2024-03-21 09:00:52
Documents
15
Period of Report
2024-03-21
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K g084141_8k.htm   iXBRL 8-K 32878
2 EXHIBIT 99.1 g084141_ex99-1.htm EX-99.1 12411
6 GRAPHIC image_003.jpg GRAPHIC 3290
  Complete submission text file 0001753926-24-000584.txt   229306

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE chro-20240321.xsd EX-101.SCH 3021
4 XBRL LABEL FILE chro-20240321_lab.xml EX-101.LAB 34240
5 XBRL PRESENTATION FILE chro-20240321_pre.xml EX-101.PRE 22363
18 EXTRACTED XBRL INSTANCE DOCUMENT g084141_8k_htm.xml XML 3753
Mailing Address 685 US HIGHWAY ONE NORTH BRUNSWICK NJ 08902
Business Address 685 US HIGHWAY ONE NORTH BRUNSWICK NJ 08902 9176446313
Chromocell Therapeutics Corp (Filer) CIK: 0001919246 (see all company filings)

IRS No.: 863335449 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41964 | Film No.: 24769660
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)